Brought to you by 
Elixir Pharmaceuticals gets $17mm with private placement
20 Oct 2003
Executive Summary
Elixir Pharmaceuticals (drugs to slow the aging process) has raised $17mm with a private placement of Series B shares to lead investors Arch Venture Partners, MPM Capital, and Oxford Bioscience Partners. Other existing investors also participated. With the second tranche, the company brought in another $19mm, for a total of $40.5mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Elixir Pharmaceuticals gets $17mm with private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice